181 related articles for article (PubMed ID: 35858874)
1. Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial.
Baltrusaitis K; Makanani B; Tierney C; Fowler MG; Moodley D; Theron G; Nyakudya LH; Tomu M; Fairlie L; George K; Heckman B; Knowles K; Browning R; Siberry GK; Taha TE; Stranix-Chibanda L;
BMC Infect Dis; 2022 Jul; 22(1):634. PubMed ID: 35858874
[TBL] [Abstract][Full Text] [Related]
2. Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial.
Stranix-Chibanda L; Tierney C; Sebikari D; Aizire J; Dadabhai S; Zanga A; Mukwasi-Kahari C; Vhembo T; Violari A; Theron G; Moodley D; George K; Fan B; Sommer MJ; Browning R; Mofenson LM; Shepherd J; Nelson B; Fowler MG; Siberry GK;
PLoS One; 2021; 16(2):e0246272. PubMed ID: 33544759
[TBL] [Abstract][Full Text] [Related]
3. Tenofovir disoproxil fumarate safety for women and their infants during pregnancy and breastfeeding.
Mofenson LM; Baggaley RC; Mameletzis I
AIDS; 2017 Jan; 31(2):213-232. PubMed ID: 27831952
[TBL] [Abstract][Full Text] [Related]
4. Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.
Rough K; Seage GR; Williams PL; Hernandez-Diaz S; Huo Y; Chadwick EG; Currier JS; Hoffman RM; Barr E; Shapiro DE; Patel K;
N Engl J Med; 2018 Apr; 378(17):1593-1603. PubMed ID: 29694825
[TBL] [Abstract][Full Text] [Related]
5. Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV Coinfection.
Kiweewa FM; Tierney C; Butler K; Peters MG; Vhembo T; Moodley D; Govender V; Mohtashemi N; Ship H; Musoke P; Dula D; George K; Chakhtoura N; Fowler MG; Currier JS; Bhattacharya D
J Acquir Immune Defic Syndr; 2022 Sep; 91(1):79-84. PubMed ID: 35621877
[TBL] [Abstract][Full Text] [Related]
6. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
[TBL] [Abstract][Full Text] [Related]
7. Renal and metabolic toxicities following initiation of HIV-1 treatment regimen in a diverse, multinational setting: a focused safety analysis of ACTG PEARLS (A5175).
Touzard Romo F; Smeaton LM; Campbell TB; Riviere C; Mngqibisa R; Nyirenda M; Supparatpinyo K; Kumarasamy N; Hakim JG; Flanigan TP
HIV Clin Trials; 2014; 15(6):246-60. PubMed ID: 25433664
[TBL] [Abstract][Full Text] [Related]
8. Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis.
Venkatesh KK; Farhad M; Fenton T; Moodley D; Naik S; Nakabiito C; Fairlie L; Fowler MG; Stringer JSA; Chi BH
AIDS; 2019 Dec; 33(15):2403-2413. PubMed ID: 31764105
[TBL] [Abstract][Full Text] [Related]
9. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
10. Development of normal reference intervals for renal function in pregnancy: a secondary analysis of clinical trial data.
Legoabe Z; Sebitloane M; Lombard C; Naidoo M; Gray G; Moodley D
J Obstet Gynaecol; 2024 Dec; 44(1):2361445. PubMed ID: 38832538
[TBL] [Abstract][Full Text] [Related]
11. Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.
Zash R; Jacobson DL; Diseko M; Mayondi G; Mmalane M; Essex M; Petlo C; Lockman S; Makhema J; Shapiro RL
JAMA Pediatr; 2017 Oct; 171(10):e172222. PubMed ID: 28783807
[TBL] [Abstract][Full Text] [Related]
12. Bone and Renal Health in Infants With or Without Breastmilk Exposure to Tenofovir-Based Maternal Antiretroviral Treatment in the PROMISE Randomized Trial.
Vhembo T; Baltrusaitis K; Tierney C; Owor M; Dadabhai S; Violari A; Theron G; Moodley D; Mukwasi-Kahari C; George K; Shepherd J; Siberry GK; Browning R; Fowler MG; Stranix-Chibanda L;
J Acquir Immune Defic Syndr; 2023 Aug; 93(5):431-437. PubMed ID: 37199427
[TBL] [Abstract][Full Text] [Related]
13. Influence of maternal use of tenofovir disoproxil fumarate or zidovudine in Vietnamese pregnant women with HIV on infant growth, renal function, and bone health.
Kinai E; Nguyen HDT; Do HQ; Matsumoto S; Nagai M; Tanuma J; Nguyen KV; Pham TN; Oka S
PLoS One; 2021; 16(4):e0250828. PubMed ID: 33914827
[TBL] [Abstract][Full Text] [Related]
14. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.
Fowler MG; Qin M; Fiscus SA; Currier JS; Flynn PM; Chipato T; McIntyre J; Gnanashanmugam D; Siberry GK; Coletti AS; Taha TE; Klingman KL; Martinson FE; Owor M; Violari A; Moodley D; Theron GB; Bhosale R; Bobat R; Chi BH; Strehlau R; Mlay P; Loftis AJ; Browning R; Fenton T; Purdue L; Basar M; Shapiro DE; Mofenson LM;
N Engl J Med; 2016 Nov; 375(18):1726-1737. PubMed ID: 27806243
[TBL] [Abstract][Full Text] [Related]
15. Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?
Foster C; Lyall H; Olmscheid B; Pearce G; Zhang S; Gibb DM
HIV Med; 2009 Aug; 10(7):397-406. PubMed ID: 19459986
[TBL] [Abstract][Full Text] [Related]
16. Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients.
Dejesus E; Young B; Morales-Ramirez JO; Sloan L; Ward DJ; Flaherty JF; Ebrahimi R; Maa JF; Reilly K; Ecker J; McColl D; Seekins D; Farajallah A;
J Acquir Immune Defic Syndr; 2009 Jun; 51(2):163-74. PubMed ID: 19357529
[TBL] [Abstract][Full Text] [Related]
17. A randomized, open-label study of the safety and efficacy of switching stavudine or zidovudine to tenofovir disoproxil fumarate in HIV-1-infected children with virologic suppression.
Saez-Llorens X; Castaño E; Rathore M; Church J; Deville J; Gaur A; Estripeaut D; White K; Arterburn S; Enejosa JV; Cheng AK; Chuck SL; Rhee MS
Pediatr Infect Dis J; 2015 Apr; 34(4):376-82. PubMed ID: 25760565
[TBL] [Abstract][Full Text] [Related]
18. Safety of tenofovir during pregnancy: early growth outcomes and hematologic side effects in HIV-exposed uninfected infants.
Seidel V; Weizsäcker K; Henrich W; Rancourt RC; Bührer C; Krüger R; Feiterna-Sperling C
Eur J Pediatr; 2020 Jan; 179(1):99-109. PubMed ID: 31659467
[TBL] [Abstract][Full Text] [Related]
19. Effects of Highly Active Antiretroviral Therapy on Renal Function and Renal Phosphate Handling in African Adults with Advanced HIV and CKD.
Adedeji TA; Adebisi SA; Adedeji NO; Biliaminu SA; Olanrewaju TO
Infect Disord Drug Targets; 2019; 19(1):88-100. PubMed ID: 30027856
[TBL] [Abstract][Full Text] [Related]
20. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL
JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
